Workflow
YISHENG(002458)
icon
Search documents
益生股份(002458) - 2020 Q3 - 季度财报
2020-10-28 16:00
山东益生种畜禽股份有限公司 2020 年第三季度报告全文 山东益生种畜禽股份有限公司 2020 年第三季度报告 2020 年 10 月 山东益生种畜禽股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人曹积生、主管会计工作负责人林杰及会计机构负责人(会计主管 人员)徐淑艳声明:保证季度报告中财务报表的真实、准确、完整。 山东益生种畜禽股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |-----------------------------------------------------|------------------|-------------------------|------------------|--------------- ...
益生股份:关于参加山东辖区上市公司2020年度投资者网上集体接待日活动的公告
2020-09-25 08:10
关于参加网上集体接待日活动的公告 证券代码:002458 证券简称:益生股份 公告编号:2020-081 本公司及董事会全体成员保证信息披露内容真实、准确和完整, 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流工作,构建和谐投资者关系, 切实提高公司透明度和治理水平,山东益生种畜禽股份有限公司(以 下简称"公司")将参加 "山东辖区上市公司 2020 年度投资者网上 集体接待日活动",现将有关事项公告如下: 本次投资者网上集体接待日活动将在深圳市全景网络有限公司 提供的网上平台采取网络远程的方式举行,投资者可以登录"全 景· 路演天下"网站(http://rs.p5w.net)参与本次活动,网上互 动交流时间为 2020 年 9 月 29 日(星期二)下午 15:00-16:55。 届时公司董事会秘书、副总裁兼财务总监林杰先生、证券事务 代表李玲女士将通过网络在线交流形式与投资者进行沟通交流,欢迎 广大投资者积极参与。 特此公告。 山东益生种畜禽股份有限公司 董事会 2020 年 09 月 26 日 山东益生种畜禽股份有限公司 关于参加山东辖区上市公司2020年度投资者 网上集体接待日活 ...
益生股份(002458) - 2020 Q2 - 季度财报
2020-08-27 16:00
Financial Performance - The company's operating revenue for the reporting period was ¥998,851,220.50, a decrease of 30.94% compared to the same period last year[33]. - The net profit attributable to shareholders was ¥204,002,961.14, down 77.42% year-on-year[33]. - The net profit after deducting non-recurring gains and losses was ¥186,619,511.82, a decline of 79.48% compared to the previous year[33]. - The net cash flow from operating activities was ¥191,848,294.84, representing a decrease of 75.54% year-on-year[33]. - Basic earnings per share were ¥0.21, down 77.17% from ¥0.92 in the same period last year[33]. - Total assets at the end of the reporting period were ¥3,915,951,049.55, a decrease of 5.43% from the end of the previous year[33]. - The net assets attributable to shareholders were ¥3,330,363,334.39, down 7.51% compared to the previous year[33]. - The weighted average return on net assets was 5.93%, a decrease of 38.86% from 44.79% in the same period last year[33]. - The company achieved an operating income of approximately ¥998.85 million in the first half of 2020, a decrease of 30.94% compared to the same period last year[64]. - Operating costs increased by 46.68% to ¥739,710,455.53 from ¥504,317,003.98, attributed to a significant increase in product sales volume[71]. - The net profit of Beidahuang Baoquanling Agricultural Development Co., Ltd. was CNY 42,108,944.67, a year-on-year decrease of 68.58%, primarily due to a decline in chicken product sales prices[94]. Dividends and Shareholder Returns - The company plans to distribute cash dividends of 1 RMB per 10 shares to all shareholders, based on a total of 990,261,363 shares[15]. - The total cash dividend distributed was CNY 99,026,136.30, representing 100% of the profit distribution total[101]. - The company’s cash dividend per 10 shares is CNY 1.00 (including tax)[101]. - The company’s cash dividend distribution plan was approved by the board and complies with relevant procedures, ensuring no harm to shareholders' rights[101]. - The company’s available distributable profit was CNY 1,054,746,833.35[101]. Operational Strategy and Market Position - The company is the largest breeding chicken producer in China and has imported Hubbard breeding stock to reduce dependency on foreign sources, aiming to enhance its core competitiveness[9]. - The company aims to increase the market share of domestically bred chicken varieties to over 60% by 2025 as part of a national genetic improvement plan[6]. - The company is focused on expanding its breeding capabilities and enhancing the quality and efficiency of imported breeds[9]. - The company is actively developing customer relationships to stabilize product quality and meet market demands, addressing risks associated with price fluctuations in poultry products[10]. - The company emphasizes the importance of a flexible and competitive breeding industry structure to support sustainable growth in the poultry sector[9]. - The company operates in the livestock industry, focusing on breeding and sales of various poultry and swine products, including parent stock broilers and breeding pigs[44]. - The company is the largest breeder of grandparent white feather broiler chickens in China, leveraging over 30 years of experience to establish unique technological and research advantages[54]. - The company has expanded its breeding scale of white feather broiler chickens and is actively developing the pig breeding industry, with multiple new pig farms under construction[64]. Risk Management and Biosecurity - The company reported a significant reliance on foreign suppliers for breeding technology, which poses risks if these suppliers reduce or stop the supply of breeding chickens due to disease or other reasons[5]. - The company is committed to improving biosecurity measures to prevent disease outbreaks that could impact its operations[11]. - The company has established strategic partnerships with multiple large raw material suppliers to mitigate risks related to price volatility of key ingredients like corn and soybean meal[15]. - The company continues to prioritize the purification and control of vertically transmitted diseases as a key area of R&D investment[71]. - The company has implemented a disease purification strategy to enhance the quality of breeding chickens, focusing on eliminating specific poultry diseases[60]. Research and Development - The company has established a comprehensive technical system with multiple R&D departments focusing on disease control, nutrition, breeding, and waste treatment[71]. - The company is actively involved in a national key research and development project aimed at enhancing the efficiency and safety of broiler chicken farming[55]. - The company achieved a significant breakthrough in breeding technologies, maintaining high levels of antibody uniformity and survival rates in parent stock chickens[71]. - Research and development expenses rose by 178.97% to ¥20,138,466.13 from ¥7,218,871.61, reflecting increased capital expenditures in R&D[71]. Environmental and Social Responsibility - The company has invested in environmental technology, establishing facilities for biological fermentation to convert livestock waste into organic fertilizer, capable of processing 120,000 tons of manure annually[60]. - The company has implemented environmental protection measures, including the removal of coal-fired boilers and installation of natural gas and biomass boilers[144]. - The company donated nearly ¥11 million to support COVID-19 prevention efforts and provided various protective materials during the pandemic[64]. Shareholder Structure and Stock Options - The total number of shares increased to 990,261,363, with the proportion of restricted shares decreasing to 37.13%[153]. - Major shareholder Cao Jisheng held 41.25% of the shares, totaling 408,467,929 shares, with a pledge of 29,002,000 shares[163]. - The company implemented a stock option incentive plan to motivate key personnel, with specific conditions for the release of locked shares[159]. - The total number of shares held by the board members and senior management has seen significant increases, with notable increases in holdings by Guo Xinmin and Ji Yongmei[184]. - The adjustments to the stock option plan indicate a proactive approach to incentivizing employees and aligning their interests with shareholder value[155]. Legal and Compliance - The company has not undergone any major litigation or arbitration matters during the reporting period, indicating a stable legal environment[112]. - The company has not received any non-standard audit reports for the previous year, suggesting compliance with financial regulations[111]. - There are no significant penalties or rectification measures imposed on the company during the reporting period, highlighting its adherence to regulatory standards[117]. - The company is currently involved in ongoing litigation related to a loan dispute, with an amount in question of 5.27 million yuan, but it does not expect to bear significant liability[115].
益生股份(002458) - 2020 Q1 - 季度财报
2020-04-29 16:00
Financial Performance - The company's revenue for Q1 2020 was ¥551,952,200.71, a decrease of 15.28% compared to ¥651,486,939.01 in the same period last year[7] - Net profit attributable to shareholders was ¥195,736,402.49, down 48.75% from ¥381,941,911.73 year-on-year[7] - The total profit for Q1 2020 was ¥197,934,860.84, a decrease of 48.09% year-on-year, primarily due to the impact of the pandemic leading to a decline in product prices and gross profit[22] - Net profit for Q1 2020 was ¥197,145,344.59, down 48.29% year-on-year, attributed to the same pandemic-related factors affecting product pricing[27] - Operating profit fell to ¥204,193,139.11 compared to ¥381,323,085.06 in the previous period, representing a decrease of about 46.5%[51] - The total comprehensive income for the period was ¥197,145,344.59, down from ¥381,276,197.99, a decline of about 48.3%[53] - The total profit for the period was 149,572,780.65, a decrease from 303,741,756.18 in the previous period, reflecting a decline of approximately 50.8%[56] - Operating profit for the current period was 155,515,140.40, down from 303,739,137.43, indicating a decrease of about 48.9%[56] Cash Flow and Liquidity - The net cash flow from operating activities was ¥109,214,350.24, representing a decline of 63.75% compared to ¥301,278,074.55 in the previous year[7] - Cash received from operating activities in Q1 2020 was ¥6,942,286.42, an increase of 168.97% year-on-year, primarily due to higher interest income[30] - Cash flow from operating activities generated a net amount of 109,214,350.24, compared to 301,278,074.55 in the previous period, representing a decline of approximately 63.7%[61] - The company reported cash inflow from investment activities of 939,808,796.34, significantly higher than 190,123.50 in the previous period[61] - The net cash flow from financing activities was -578,804,343.41, compared to -62,295,832.09 in the previous period, indicating a worsening of approximately 828.5%[63] - The company paid 577,274,541.00 in dividends and interest, compared to 4,315,832.09 in the previous period, reflecting a significant increase[63] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,585,037,081.47, a decrease of 13.42% from ¥4,140,859,202.23 at the end of the previous year[7] - The company's net assets attributable to shareholders were ¥3,231,388,696.21, down 10.26% from ¥3,600,728,050.97 at the end of the previous year[7] - Total liabilities decreased to ¥345,705,925.03 from ¥533,597,633.13, reflecting a decline of about 35.2%[40] - The company's equity attributable to shareholders decreased to ¥3,231,388,696.21 from ¥3,600,728,050.97, a decrease of approximately 10.2%[42] - Current assets totaled ¥1,173,761,262.78, down from ¥1,710,317,008.91, indicating a decrease of about 31.3%[36] - The balance of accounts payable as of March 31, 2020, was ¥117,014,257.21, a decrease of 52.39% compared to the end of 2019, due to payments made for the purchase of remaining debts and equity[7] Research and Development - Research and development expenses for Q1 2020 amounted to ¥5,866,967.21, an increase of 33.45% year-on-year, reflecting continued investment in research[17] - Research and development expenses increased to ¥5,866,967.21 from ¥4,396,236.04, reflecting a growth of about 33.5% year-over-year[49] Other Income and Gains - The company reported a non-recurring gain of ¥28,382,714.15 during the period[7] - The company reported a significant increase in other income for Q1 2020, totaling ¥1,418,772.82, which is up 304.67% year-on-year, mainly due to increased government subsidies[19] Shareholder Activities - The company did not conduct any repurchase transactions among the top 10 shareholders during the reporting period[16] - The company’s capital reserve as of March 31, 2020, was ¥480,211,463.79, a decrease of 45.21% year-on-year, mainly due to the transfer of capital reserve to increase share capital[14] Changes in Accounting Standards - The company implemented new revenue and leasing standards starting January 1, 2020, affecting the financial statements[68] - The company adopted the new revenue recognition standard starting January 1, 2020, adjusting pre-receipts to contract liabilities[76] Company Leadership - The chairman of the company is Cao Jisheng, as of April 30, 2020[80]
益生股份(002458) - 2019 Q4 - 年度财报
2020-02-19 16:00
Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in 2019[18]. - The company's operating revenue for 2019 was CNY 3,583,534,105.26, representing a 143.26% increase compared to the previous year[6]. - The net profit attributable to shareholders for 2019 was CNY 2,176,039,144.86, showing a significant increase of 499.73% year-over-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 2,175,209,364.60, reflecting a 498.29% increase compared to the previous year[6]. - The net cash flow from operating activities for 2019 was CNY 2,134,744,427.38, an increase of 397.85% year-over-year[6]. - Basic earnings per share for 2019 were CNY 3.79, up 501.59% from CNY 0.63 in 2018[6]. - The diluted earnings per share for 2019 were CNY 3.77, representing a 498.41% increase compared to the previous year[6]. - The weighted average return on equity for 2019 was 83.18%, an increase of 57.36 percentage points from 25.82% in 2018[6]. - Total assets at the end of 2019 were CNY 4,140,859,202.23, a 79.21% increase from CNY 2,310,623,565.50 at the end of 2018[6]. - The net assets attributable to shareholders at the end of 2019 were CNY 3,600,728,050.97, reflecting a 125.73% increase compared to CNY 1,595,173,638.53 at the end of 2018[6]. Market Expansion and Strategy - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[18]. - The company aims to increase its production capacity by 20% in the upcoming fiscal year to meet growing market demand[18]. - The company is exploring potential mergers and acquisitions to accelerate growth and expand its market share[18]. - The company has established strategic partnerships to enhance its supply chain efficiency and reduce operational costs[18]. - The company is actively developing its pig breeding business, leveraging successful experiences from its chicken breeding operations[121]. Product Development and Innovation - The company has introduced the new Lifen breed of white feather broiler chickens, which shows significant advantages in egg production rate and feed-to-meat ratio compared to older breeds[63]. - The company has successfully developed a new chicken breed "Yisheng 909," which is currently in the trial promotion stage, showing significant advantages over mainstream breeds[92]. - The company is focusing on the development of white feather broiler chicken, which has become a leading meat consumption product in developed countries[116]. Sustainability and Environmental Practices - The company is committed to sustainable practices and has invested in environmentally friendly technologies to reduce its carbon footprint[18]. - The company emphasizes environmental sustainability by promoting the use of organic fertilizers derived from waste, contributing to a circular economy[118]. - The company’s organic fertilizer production utilizes waste from poultry farming, contributing to sustainable agricultural practices[48]. Operational Efficiency and Cost Management - The company reported a net profit margin of 12% for the fiscal year 2019, reflecting effective cost management strategies[18]. - The company has implemented strict biosecurity measures to mitigate risks from poultry diseases, including batch management and full entry-exit protocols[131]. - The company faces risks related to raw material price fluctuations, particularly for corn and soybean meal, which significantly impact production costs[132]. - The company is addressing the risk of price fluctuations in the poultry market by enhancing customer development and maintaining product quality[130]. Research and Development - Research and development (R&D) expenses increased by 50.99% to ¥29,503,969.37, primarily due to new R&D projects[90]. - The total R&D investment amounted to ¥75,300,830.65, a significant increase of 231.88% compared to the previous year[98]. - The number of R&D personnel increased by 11.76% to 38, maintaining a stable proportion of 0.96% of the total workforce[94]. Shareholder Returns and Dividends - The company plans to distribute a cash dividend of 10.00 RMB per 10 shares (including tax) to all shareholders, based on a total share capital of 577,045,341 shares[6]. - In 2019, the cash dividend represented 34.43% of the net profit attributable to ordinary shareholders, amounting to RMB 749,253,068.40[141]. - The company has not proposed any stock dividends for the year 2019, maintaining a focus on cash dividends[144]. Industry Position and Challenges - The company operates in a highly cyclical industry, with a breeding cycle that requires over six months before economic returns are realized[54]. - The company faces a supply shortage of white feather broiler breeding stock due to import restrictions from major exporting countries, with annual imports falling below 750,000 sets from 2015 to 2018[53]. - The livestock industry is positioned for growth, with significant opportunities for industrialized operations amid ongoing agricultural supply-side reforms in China[49]. Financial Management and Governance - The company has not experienced any significant accounting errors requiring retrospective restatement during the reporting period[159]. - The company has maintained its accounting firm, He Xin Accounting Firm, for four consecutive years, with an audit fee of CNY 900,000[161]. - The company has not faced any penalties or rectification issues during the reporting period[169].
益生股份(002458) - 2019 Q3 - 季度财报
2019-10-27 16:00
山东益生种畜禽股份有限公司 2019 年第三季度报告全文 山东益生种畜禽股份有限公司 2019 年第三季度报告 2019 年 10 月 山东益生种畜禽股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人曹积生、主管会计工作负责人林杰及会计机构负责人(会计主管 人员)徐淑艳声明:保证季度报告中财务报表的真实、准确、完整。 山东益生种畜禽股份有限公司 2019 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |-----------------------------------------------------|------------------|-------------------------|------------------|--------------- ...
益生股份(002458) - 2019 Q2 - 季度财报
2019-07-24 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was CNY 1,446,291,289.47, representing an increase of 188.07% compared to CNY 502,062,554.73 in the same period last year[22] - Net profit attributable to shareholders was CNY 903,514,666.04, a significant increase of 2,688.67% from CNY 32,399,430.01 in the previous year[22] - The net profit after deducting non-recurring gains and losses reached CNY 909,237,360.23, up 2,796.86% from CNY 31,386,948.24 year-on-year[22] - The net cash flow from operating activities was CNY 784,476,321.83, a remarkable increase of 5,604.80% compared to CNY 13,751,165.50 in the same period last year[22] - Basic earnings per share were CNY 1.58, compared to CNY 0.06 in the previous year, marking an increase of 2,533.33%[22] - Total assets at the end of the reporting period were CNY 2,780,403,391.17, reflecting a growth of 20.33% from CNY 2,310,623,565.50 at the end of the previous year[22] - Net assets attributable to shareholders increased to CNY 2,445,829,438.88, up 53.33% from CNY 1,595,173,638.53 at the end of the previous year[22] - The weighted average return on equity was 44.79%, a significant increase from 2.63% in the previous year[22] Dividend and Shareholder Information - The company plans to distribute a cash dividend of CNY 3.00 per 10 shares, totaling CNY 172,207,577.74 based on the total share capital of 574,025,758 shares[6] - The total number of shares increased from 337,378,701 to 574,025,758 after a capital increase of 236,165,090 shares through a bonus issue[167] - The proportion of limited shares decreased from 46.49% to 38.08% following the conversion of 89,995,786 shares from limited to unrestricted[166] - The total number of common shareholders at the end of the reporting period was 60,660[175] - The largest shareholder, Cao Jisheng, holds 41.86% of the shares, totaling 240,275,252 shares, with a decrease of 6,620,000 shares during the reporting period[175] Business Operations and Industry Position - The company operates in the livestock industry, focusing on breeding and sales of various poultry and livestock products, including parent stock broilers and pigs[33] - The main products include parent stock broiler chicks, parent stock layer chicks, commodity broiler chicks, breeding pigs, and organic fertilizers[34] - The company has established a breeding process for parent stock broiler chicks, utilizing both imported and self-bred stock, ensuring a steady supply for downstream breeding enterprises[35] - The company is positioned to leverage opportunities in the livestock sector, with ongoing support from government policies aimed at enhancing agricultural productivity[42] - The chicken industry is the second largest meat consumption category in China, with the white feather broiler industry being a significant part of modern animal husbandry[43] Environmental and Regulatory Compliance - Environmental protection regulations have been implemented, promoting sustainable development in the poultry industry, with a focus on waste management and resource utilization[48] - The company has replaced all coal-fired boilers with natural gas and biomass boilers to reduce air pollution and is actively researching heat recovery technology for chicken houses[160] - The company does not belong to the key pollutant discharge units as published by environmental protection departments and has implemented effective pollution prevention measures[160] Research and Development - Research and development expenses increased by 27.19% to RMB 7,218,871.61, highlighting the company's commitment to innovation and product quality[72] - The company has established a comprehensive technical system to support various breeding species, enhancing research and development capabilities[68] Risks and Challenges - The company faces risks related to reliance on foreign suppliers for breeding technology, which could impact business operations if supply is disrupted[91] - The company faces risks from raw material price fluctuations, particularly for feed ingredients like corn and soybean, which significantly impact production costs[97] Legal and Corporate Governance - The company did not face any significant adverse impacts from major diseases or natural disasters during the reporting period[68] - There are no major litigation or arbitration matters reported during the reporting period[117] - The company has not faced any penalties or rectification issues during the reporting period[122] - The half-year financial report has not been audited[116] Shareholder Engagement and Stock Options - The company has made commitments to encourage employees to invest in its stock, with a compensation plan for any losses incurred during a specified period[113] - The company’s stock option plan saw 481,967 options exercised by June 28, 2019, impacting the total share count[167]
益生股份(002458) - 2019 Q1 - 季度财报
2019-04-24 16:00
Financial Performance - The company's revenue for Q1 2019 reached ¥651,486,939.01, representing a 193.55% increase compared to ¥221,934,934.18 in the same period last year[7] - Net profit attributable to shareholders was ¥381,941,911.73, a significant increase of 3,503.70% from ¥10,598,605.80 in the previous year[7] - Basic earnings per share increased to ¥0.67, up 3,250.00% from ¥0.02 in the previous year[7] - Operating revenue for Q1 2019 was ¥651,486,939.01, a 193.55% increase year-over-year, driven by substantial price hikes of main products[14] - Net profit for Q1 2019 reached ¥381,276,197.99, reflecting a remarkable increase of 3,708.62% compared to the same period last year, mainly due to increased product prices[16] - Operating profit for Q1 2019 was CNY 381,323,085.06, compared to CNY 6,837,185.48 in Q1 2018, indicating a substantial improvement in profitability[42] - The total profit for Q1 2019 was CNY 381,276,197.99, compared to CNY 10,010,873.21 in Q1 2018, marking a significant increase[42] Cash Flow - The net cash flow from operating activities was ¥301,278,074.55, showing a remarkable improvement of 938.69% compared to -¥35,922,308.07 in the same period last year[7] - Cash received from sales and services in Q1 2019 was ¥642,407,239.63, an increase of 206.81% year-over-year, resulting from higher sales revenue[16] - The company reported cash inflows from operating activities totaling ¥644,988,350.66, compared to ¥210,724,461.37 in the previous period, marking an increase of about 205.5%[50] - The net cash flow from operating activities was ¥191,880,063.29, a significant improvement from the previous period's net cash flow of -¥68,174,433.30[53] - Cash inflow from operating activities totaled ¥693,396,777.26, compared to ¥245,470,918.63 in the prior period, indicating a growth of approximately 182%[53] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,563,047,179.00, a 10.92% increase from ¥2,310,623,565.50 at the end of the previous year[7] - Total liabilities decreased to ¥641,371,318.83 from ¥705,763,426.12, indicating a reduction of approximately 9.1%[30] - Current assets increased to ¥717,517,267.64 as of March 31, 2019, up from ¥481,446,226.06 on December 31, 2018, representing a growth of approximately 49.0%[26] - Total non-current assets amounted to ¥1,845,529,911.36, slightly up from ¥1,829,177,339.44, showing a growth of approximately 0.9%[28] - Total equity increased to CNY 1,757,173,685.93 from CNY 1,517,892,406.95, representing a growth of approximately 15.7%[40] Shareholder Information - The top shareholder, Cao Jisheng, holds 41.89% of the shares, with a total of 141,338,384 shares[9] - The company did not engage in any repurchase transactions during the reporting period[11] Research and Development - Research and development expenses for Q1 2019 amounted to ¥4,396,236.04, up 146.23% year-over-year, due to increased investments in disease purification and biosecurity systems[14] - Research and development expenses for Q1 2019 were CNY 4,396,236.04, up from CNY 1,785,384.65 in the previous year, indicating a focus on innovation and development[40] Financial Expenses and Income - Financial expenses decreased by 43.92% to ¥3,730,140.85 in Q1 2019, due to reduced bank loan balances and increased interest income[14] - The company reported an investment income of ¥11,699,759.54 for Q1 2019, a 273.16% increase year-over-year, primarily from profits of an associated company[14] - The company reported investment income of CNY 11,699,759.54, a recovery from a loss of CNY 6,756,622.78 in the same period last year[40] Other Financial Metrics - The weighted average return on equity was 21.37%, a significant increase from 0.87% in the previous year[7] - The company's gross profit margin improved significantly, contributing to a 213.72% increase in retained earnings to ¥461,608,334.55 as of March 31, 2019[14]
益生股份(002458) - 2018 Q4 - 年度财报
2019-02-19 16:00
Financial Performance - The company's operating revenue for 2018 was approximately RMB 1.47 billion, representing a 124.42% increase compared to the previous year [23]. - The net profit attributable to shareholders for 2018 was approximately RMB 362.84 million, a significant turnaround from a loss of RMB 310.37 million in 2017, marking a 216.91% increase [23]. - The net cash flow from operating activities reached approximately RMB 428.80 million, a 405.11% increase from a negative cash flow of RMB 140.99 million in 2017 [23]. - The total assets of the company at the end of 2018 were approximately RMB 2.31 billion, reflecting a 7.75% increase from the previous year [26]. - The net assets attributable to shareholders increased by 31.57% to approximately RMB 1.60 billion at the end of 2018 [26]. - The basic earnings per share for 2018 was RMB 1.08, compared to a loss of RMB 0.92 per share in 2017, indicating a 217.39% improvement [23]. - The company reported a weighted average return on equity of 25.82% for 2018, a significant recovery from -23.13% in 2017 [23]. - The company achieved an operating revenue of 1,473.12 million CNY, representing a growth of 124.42% compared to the previous year [68]. - The net profit attributable to shareholders reached 362.84 million CNY, marking a significant increase of 216.91% from the previous year [68]. Dividend Distribution - The company plans to distribute a cash dividend of 2.00 RMB per 10 shares (including tax) to all shareholders, based on a total share capital of 337,378,701 shares [6]. - The company distributed a cash dividend of RMB 2.00 per 10 shares, totaling RMB 67,475,740.20 (including tax), which represents 18.60% of the net profit attributable to shareholders [138]. Business Operations and Stability - The company has not reported any changes in its main business since its listing, indicating stability in operations [22]. - The company did not experience any significant changes in its main products during the reporting period [37]. - The main business activities include breeding and sales of various poultry and livestock, as well as production and sales of feed and organic fertilizers [39]. - The company has not disclosed any significant differences in net profit and net assets between international and Chinese accounting standards during the reporting period [27]. Research and Development - The company has maintained its commitment to research and development in livestock and poultry breeding technologies, aiming to enhance product quality and yield [21]. - The company has established multiple functional R&D departments focusing on disease control, nutrition, breeding, and waste treatment, enhancing its technical capabilities [73]. - The company achieved significant progress in the purification control research of avian leukosis, becoming the first domestic enterprise to pass the national "Avian Leukosis Purification Demonstration Farm" acceptance [96]. - The company continues to enhance its research on vertical transmission diseases, with notable advancements in the control of mycoplasma diseases [98]. - The company is focusing on new product development and technology improvements to enhance product quality and market share [98]. Market Position and Industry Trends - The poultry industry is the second largest meat consumption category in China, with a significant focus on the white feather broiler sector [45]. - The company is positioned to benefit from national policies supporting the livestock industry, which emphasize scale, standardization, and modernization [46]. - The company is the only domestic enterprise with the great-grandparent generation of white feather broilers, importing Hubbard great-grandparent white feather broilers and breeding them into grandparent generation [48]. - The national genetic improvement plan aims to cultivate over 40 new chicken varieties by 2025, with a market share of over 60% for self-bred varieties [49]. - The overall industry for white feather broiler chickens is experiencing a recovery, with rising prices driven by supply constraints and increased demand [65]. Environmental and Social Responsibility - The company focuses on the comprehensive utilization of poultry waste to meet national pollution prevention requirements, allowing for tax reductions [51]. - The company is implementing a livestock pollution control project through its wholly-owned subsidiary, which aligns with national policies on circular economy and environmental protection [195]. - The company actively participates in social responsibility initiatives, funding local infrastructure projects and providing scholarships to impoverished students, contributing hundreds of thousands of yuan over the years [199]. Challenges and Risks - The company faces risks related to price fluctuations in poultry products and plans to enhance customer development to stabilize sales [128]. - The company has faced risks related to the outbreak of poultry diseases and has implemented strict biosecurity measures to mitigate these risks [129]. - The company is exposed to fluctuations in raw material prices, particularly corn and soybean meal, which significantly impact production costs [132]. - The company has not distributed cash dividends in 2016 and 2017 due to negative net profits, indicating a focus on maintaining liquidity for operations [136][137]. Strategic Partnerships and Supply Chain - The company has established a long-term strategic partnership with foreign breeding suppliers to secure the supply of grandparent stock chickens [71]. - The company has imported Hubbard grandparent white feather broiler chickens, reducing reliance on foreign suppliers for breeding stock [127]. - The company is actively exploring partnerships with leading enterprises to reduce industry volatility risks and enhance product value [120]. Financial Management and Reporting - The company has integrated various financial reporting items to streamline its financial statements, enhancing clarity [153]. - The company has maintained a strong asset quality with all subscribed funds being legally sourced [149]. - The company has not reported any significant accounting errors that require retrospective restatement for the reporting period [157]. - The company has no significant litigation or arbitration matters pending [161].
益生股份(002458) - 2018 Q3 - 季度财报
2018-10-15 16:00
山东益生种畜禽股份有限公司 2018 年第三季度报告正文 证券代码:002458 证券简称:益生股份 公告编号:2018-084 山东益生种畜禽股份有限公司 2018 年第三季度报告正文 山东益生种畜禽股份有限公司 2018 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人曹积生、主管会计工作负责人林杰及会计机构负责人(会计主管 人员)徐淑艳声明:保证季度报告中财务报表的真实、准确、完整。 山东益生种畜禽股份有限公司 2018 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 2,225,931,000.98 | | 2,144,391,505.23 | 3.80% | | 归属于 ...